Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04506996
Other study ID # 00007115
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 9, 2016
Est. completion date September 27, 2018

Study information

Verified date August 2020
Source Johns Hopkins Bloomberg School of Public Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study, involves the implementation and evaluation of a Monday-focused, individually tailored mobile health application to assist overweight or obese adults who would like to achieve a healthful weight. The goal was to evaluate the application of a Monday-focused delivery system for the M-TRIMM2 intervention on participants who worked or lived in areas in or adjacent to Johns Hopkins East Baltimore medical campus.Targeting mobile messaging occurred at strategic intervals throughout each week, with the intent of prompting participants to renew their health resolutions each Monday combined with lifestyle behavioral education.


Description:

The specific aims of this research project are to:

1. Develop a targeted delivery system for mobile health messages which focused on improving physical activity and diet, and setting healthy resolutions each week.

2. Deliver the M-TRIMM intervention, which encourages healthy behavior and the weekly renewal of health resolutions.

3. Evaluate the effectiveness of this intervention on individuals' weight loss, self-efficacy, and motivation to sustain changes in lifestyle behaviors.

4. Assess the benefit of receiving the message content only (in a paper document), versus a scheduled weekly delivery via mobile messaging.


Recruitment information / eligibility

Status Completed
Enrollment 154
Est. completion date September 27, 2018
Est. primary completion date September 27, 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- age = 18 and <71

- BMI > 25

- having a phone that was capable of receiving text-messages and being willing to receive text-messages

Exclusion Criteria:

- age <18 or = 71

- BMI = 25

- not having a phone that was capable of receiving text-messages or not being willing to receive text-messages

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management
see arm/group descriptions
Monday-Focused Written Messages for Weight Management
see arm/group descriptions
Educational Materials
After the baseline assessment and the 1st follow-up (~8 weeks post randomization), participants received educational materials regarding physical activity and healthier diets. The study staff reviewed these materials with the participants

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Johns Hopkins Bloomberg School of Public Health

Outcome

Type Measure Description Time frame Safety issue
Other Change from baseline in self-efficacy to lose weight Weight Efficacy Lifestyle Questionnaire (Clark, Abrams,& Niaura, 1991) ~8 weeks, ~16 weeks, and ~42 weeks post-randomization compared to baseline
Other Physical activity change from baseline International Physical Activity Questionnaire - was used to calculate the total metabolic equivalents (MET)-minutes per week, and MET-minutes per week for four domains of physical activity: (1) PA activity performed at work or during volunteer activities, (2) transportation-related PA (such as walking to do errands), (3) PA performed during housework and caring for family, and (4) recreational, sport, and leisure-time PA. ~8 weeks, ~16 weeks, and ~42 weeks post-randomization compared to baseline
Other Change from baseline in fruit and vegetable servings intake from baseline National Cancer Institute's (NCI) 19-item All -Day Fruit and Vegetable Screener was used to calculate daily averages of fruit and vegetable serving intake, using NCI's 2001 scoring protocol. ~8 weeks, ~16 weeks, and ~42 weeks post-randomization compared to baseline
Other Change from baseline in percent energy from fat intake National Cancer Institute's 17-item Percent Energy from Fat Screener - All-Day Quick Food Scan was used and scored according to NCI's 2004 protocol. ~8 weeks, ~16 weeks, and ~42 weeks post-randomization compared to baseline
Other Change from baseline in scores of perceived exercise benefits and barriers to engaging in exercise and physical activity The 43-item Exercise Benefits and Barriers Scale was used. Separate scores will be calculated for perceived benefits and for perceived barriers. (Sechrist, Walker, & Pender, 1987) ~8 weeks, ~16 weeks, and ~42 weeks post-randomization compared to baseline
Other Comparison of satisfaction with the program and suggestions for improvement between intervention and control groups Participants completed a questionnaire that included quantitative and qualitative questions.
Most of the qualitative questions sought to assess what parts of the program worked well and what could have been done better. For instance, participants were asked for their suggestions about what could be done to improve the M-TRIMM2 program, what messages they liked and did not like, and why they would or would not recommend the program to their friends.
The quantitative questions covered a variety of topics, including participants engagement with the program (i.e. whether the participants read the messages they received), how useful messages were in helping participants reach the eight study goals (i.e. eating only when hungry, and exercising more), how helpful the goals were helping participants to achieve weight loss, and whether the program helped participants commit to new goals each Monday during the intervention.
~16 weeks, and ~42 weeks post-randomization compared to baseline
Primary Percent change in weight from baseline ~8 weeks, ~16 weeks, and ~42 weeks post-randomization
Secondary Body Mass Index (BMI) change from baseline BMI = kg/m2 ~8 weeks, ~16 weeks, and ~42 weeks post-randomization
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2
Completed NCT05040971 - Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes Phase 3